




Searching News Database: Sirna Therapeutics
HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
HSMN NewsFeed - 19 Dec 2012
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
HSMN NewsFeed - 22 May 2008
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
HSMN NewsFeed - 19 Sep 2007
Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner
Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner
HSMN NewsFeed - 8 Mar 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
HSMN NewsFeed - 29 Dec 2006
Merck & Co., Inc. Announces Completion of Acquisition of Sirna Therapeutics, Inc.
Merck & Co., Inc. Announces Completion of Acquisition of Sirna Therapeutics, Inc.
HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
HSMN NewsFeed - 21 Aug 2006
Alnylam Grants Calando a License to Develop and Commercialize an RNAi Therapeutic Product
Alnylam Grants Calando a License to Develop and Commercialize an RNAi Therapeutic Product
HSMN NewsFeed - 11 Aug 2006
Calando Pharmaceuticals Appoints Jeremy D. Heidel as Chief Scientific Officer
Calando Pharmaceuticals Appoints Jeremy D. Heidel as Chief Scientific Officer
HSMN NewsFeed - 4 May 2006
Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKline
Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKline
Additional items found! 23

Members Archive contains
23 additional stories matching:
Sirna Therapeutics
(Password required)
Sirna Therapeutics
(Password required)